NASDAQ · Biotechnology
MDCX (MDCX) Stock
$0.28
-12.01%
NASDAQ: MDCX
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
UGG's cozy bedding set is on rare sale for $70 at Macy's
TheStreet · Jul 17, 2026
Emmy Predictions: What Happens When One Network Has the Two Most-Nominated Series?
Variety · Jul 17, 2026
Dow Jones Futures: Micron, Sandisk, Google Lead AI Sell-Off, Netflix Dives Late; SpaceX Starship Launch Scrubbed
Investor's Business Daily · Jul 17, 2026
BuzzFeed, Inc. Appoints Stanley E. Washington to Board of Directors
Business Wire · Jul 17, 2026
US to Impose 25% Section 301 Tariff on Certain Brazilian Imports
MT Newswires · Jul 17, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held12.48%
Institutions Held4.08%
Institutions Float Held4.67%
Peer Comparison
About MDCX
MDCX is led by CEO Raza Bokhari, employs 12 people, headquartered in CA, publicly traded since 2024.
MDCX stock trades at $0.28 with a market capitalization of $6.17M. The stock is valued at a price-to-earnings (P/E) ratio of -0.71, price-to-book of 10.27, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.25 and $3.69, and currently trades 92.4% below its 52-week high.
On profitability, MDCX generates a return on equity (ROE) of -2865.18%, an operating margin of 0.00%, a net profit margin of 0.00%.